These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34690008)

  • 21. Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: a 5-year review.
    Haddad P; Wong RK; Pond GR; Soban F; Williams D; McLean M; Levin W; Bezjak A
    Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):430-4. PubMed ID: 16149286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials.
    Sze WM; Shelley MD; Held I; Wilt TJ; Mason MD
    Clin Oncol (R Coll Radiol); 2003 Sep; 15(6):345-52. PubMed ID: 14524489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multifraction radiotherapy for palliation of painful bone metastases: 20 Gy versus 30 Gy.
    Valeriani M; Scaringi C; Blasi L; Carnevale A; De Sanctis V; Bonome P; Bracci S; Marrone G; Minniti G; Enrici RM
    Tumori; 2015; 101(3):318-22. PubMed ID: 25908049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular breast cancer subtypes and therapies in a public hospital of northeastern Brazil.
    de Macêdo Andrade AC; Ferreira Júnior CA; Dantas Guimarães B; Pessoa Barros AW; Sarmento de Almeida G; Weller M
    BMC Womens Health; 2014 Sep; 14():110. PubMed ID: 25216732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palliative radiotherapy improves pain and reduces functional interference in patients with painful bone metastases: a quality assurance study.
    Wu JS; Monk G; Clark T; Robinson J; Eigl BJ; Hagen N
    Clin Oncol (R Coll Radiol); 2006 Sep; 18(7):539-44. PubMed ID: 16969984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of concurrent capecitabine and external beam radiotherapy for pain control of bone metastases of breast cancer origin.
    Kundel Y; Nasser NJ; Purim O; Yerushalmi R; Fenig E; Pfeffer RM; Stemmer SM; Rizel S; Symon Z; Kaufman B; Sulkes A; Brenner B
    PLoS One; 2013; 8(7):e68327. PubMed ID: 23874586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Palliative radiotherapy of bone metastases. Comparison between 2 fractionations].
    Peretti G; Belfiore G; Nuzzo A; Morera E; Basilico L
    Radiol Med; 1984 Jun; 70(6):393-5. PubMed ID: 6085411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Using Audit Data to Improve the Evidence-Based Use of Single-Fraction Radiation Therapy for Bone Metastases in British Columbia.
    Olson RA; Tiwana M; Barnes M; Cai E; McGahan C; Roden K; Yurkowski E; Gentles Q; French J; Halperin R; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):40-47. PubMed ID: 26281828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized trial.
    Westhoff PG; de Graeff A; Geerling JI; Reyners AK; van der Linden YM
    BMC Cancer; 2014 May; 14():347. PubMed ID: 24885354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of practice in palliative radiotherapy for painful bone metastases: a survey in Japan.
    Nakamura N; Shikama N; Wada H; Harada H; Nozaki M; Nagakura H; Tago M; Oguchi M; Uchida N;
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e117-20. PubMed ID: 22381902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastatic behavior of breast cancer subtypes.
    Kennecke H; Yerushalmi R; Woods R; Cheang MC; Voduc D; Speers CH; Nielsen TO; Gelmon K
    J Clin Oncol; 2010 Jul; 28(20):3271-7. PubMed ID: 20498394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-reported symptoms before palliative radiotherapy predict survival differences.
    Nieder C; Kämpe TA; Pawinski A; Dalhaug A
    Strahlenther Onkol; 2018 Jun; 194(6):533-538. PubMed ID: 29344766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice.
    Lim YJ; Lee SW; Choi N; Kwon J; Eom KY; Kang E; Kim EK; Kim SW; Kim JH; Kim YJ; Kim SH; Park SY; Kim JS; Kim IA
    Breast Cancer Res Treat; 2017 Jun; 163(3):555-563. PubMed ID: 28315066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.
    Chow E; Meyer RM; Ding K; Nabid A; Chabot P; Wong P; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; Brundage M; DeAngelis C; Wong RKS
    Lancet Oncol; 2015 Nov; 16(15):1463-1472. PubMed ID: 26489389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropathic Pain Features in Patients with Bone Metastases.
    Nakamura N; Takahashi O; Zenda S; Kawamori J; Ogita M; Onozawa M; Arahira S; Toshima M; Motegi A; Hirano Y; Hojo H; Akimoto T
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):204-8. PubMed ID: 26537667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.
    Torres-Roca JF; Fulp WJ; Caudell JJ; Servant N; Bollet MA; van de Vijver M; Naghavi AO; Harris EE; Eschrich SA
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):631-8. PubMed ID: 26461005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Palliative radiotherapy for symptomatic osseous metastases].
    Shigematsu N; Ito H; Toya K; Ko W; Kutsuki S; Tsukamoto N; Kubo A; Dokiya T; Yorozu A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Aug; 55(9):677-81. PubMed ID: 7478954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer.
    Hess G; Barlev A; Chung K; Hill JW; Fonseca E
    Radiat Oncol; 2012 Oct; 7():168. PubMed ID: 23062178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent Use of Extended Fractionation Palliative Radiotherapy for Medicare Beneficiaries With Metastatic Breast Cancer, 2011 to 2014.
    Yu JB; Pollack CE; Herrin J; Zhu W; Soulos PR; Xu X; Gross CP
    Am J Clin Oncol; 2019 Jun; 42(6):493-499. PubMed ID: 31033511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.